Sterile, bioavailable, and clinically validated ocular formulations manufactured under strict cGMP protocols for anterior and posterior eye care.
Sodium Hyaluronate Ophthalmic Solution 0.1% w/v (10ml)
Viscoelastic mucin-mimicking polymer with prolonged corneal residence time. Relieves moderate-to-severe dry eye and speeds epithelial recovery.
Moxifloxacin Hydrochloride 0.5% w/v (5ml)
4th-generation fluoroquinolone inhibiting bacterial DNA gyrase and topoisomerase IV. Broad bactericidal efficacy for bacterial conjunctivitis.
Moxifloxacin 0.5% + Dexamethasone 0.1% (5ml)
Dual synergistic formulation controlling ocular infection while suppressing inflammatory cascades post-cataract and refractive surgery.
Dexamethasone Sodium Phosphate 0.1% w/v (10ml)
Potent glucocorticoid for anterior uveitis, non-infectious conjunctivitis, corneal injury, and post-surgical ocular inflammation.
Nepafenac Ophthalmic Suspension 0.1% w/v (5ml)
Targeted NSAID pro-drug converted into amfenac intraocularly. Prevents cystoid macular edema (CME) and relieves post-cataract pain.
Carboxymethylcellulose Sodium 0.5% w/v (10ml)
Electrolyte-balanced lubricating eye drops that protect the cornea against screen glare, environmental dry air, and air-conditioning strain.
Carboxymethylcellulose Sodium 1.0% w/v
High-viscosity lubricating eye gel for intensive corneal surface regeneration and overnight dry eye relief.
Tobramycin Ophthalmic Solution 0.3% w/v (5ml)
Potent aminoglycoside bactericidal solution for superficial ocular infections caused by susceptible pathogens.
Olopatadine Hydrochloride Ophthalmic Solution 0.1% (5ml)
Dual-action antihistamine and mast-cell stabilizer for swift relief of ocular itch, conjunctival chemosis, and redness.
Astaxanthin, Lutein, Zeaxanthin & Omega-3 Fatty Acids
Advanced carotenoid antioxidant formulation protecting the retinal pigment epithelium against ARMD and diabetic retinopathy.
